Otologic Pharmaceutics

Otologic Pharmaceutics, Inc. (OP) is an Oklahoma headquartered organization formed specifically to commercialize promising technologies that address novel pharmacological solutions for hearing and balanced health.  The combined research and business experience of the Hough Ear Institute, (“HEI”), Oklahoma Medical Research Foundation, (“OMRF”) and American BioHealth Group, (“ABG”), have aligned under Otologic Pharmaceutics, Inc. to discover and commercialize therapeutic agents to combat the debilitating effects of sensorineural hearing loss (SNHL). Our Vision Is To Cure Hearing Loss.